This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Posted on 26 February 2018 | 3:57 am
Pharmaceuticals industry 'facing its own
TechCentralPharmaceuticals industry 'facing its own Y2K'TechCentralThe private healthcare industry is gearing up for a coding structure change that is to come into effect from 1 March 2018, whereby the existing coding conventions for anything from medicines to wheelchairs and surgical supplies will migrate from six to ...
Posted on 26 February 2018 | 12:54 am
InDex Pharmaceuticals Holding AB (publ) Year
InDex Pharmaceuticals Holding AB (publ) Year end Report 2017PR Newswire (press release)In addition, this raises the profile of cobitolimod among potential partners and key opinion leaders within the therapeutic field with whom the major pharmaceutical companies consult for their transactions. In early February, another major transaction ...and more »
Posted on 25 February 2018 | 11:46 pm
Pharmaceuticals unlikely to avoid a harsh
Pharmaceuticals unlikely to avoid a harsh BrexitIrish ExaminerOne of the big concerns for the Irish Pharmaceutical Healthcare Association (IPHA) is that the supply of many commonly used medicines such as Aspirins, Paracetamols, Strepsils, Lemsips etc, imported daily from the UK, will be disrupted. But also a wide ...
Posted on 25 February 2018 | 11:34 pm
Will Valeant Pharmaceuticals' Turnaround
Will Valeant Pharmaceuticals' Turnaround Fizzle with Its Q4 Results?Fox BusinessValeant's divestitures also impacted its revenue in the third quarter. The company closed on its sale of skin care products CeraVe, AcneFree, and AMBI in March 2017. An even bigger hit came from the divestiture of Dendreon in late June. But the full ...Valeant: Can Bulls Stomach Double-Digit Revenue Declines?Seeking AlphaValeant Pharmaceuticals (VRX) PT Raised to $18 at Canaccord GenuityStreetInsider.comall 3 news articles »
Posted on 25 February 2018 | 6:52 pm
NovaBay Pharmaceuticals to Offer Educational
At the April 19 workshop and dinner, nationally prominent eye experts will describe improvements in lid hygiene regimens made possible by NovaBay's Avenova lid cleanser EMERYVILLE, CA / ACCESSWIRE / April ...
Posted on 10 April 2015 | 9:25 am
Adamas Pharmaceuticals Receives Orphan Drug
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia ...
Posted on 10 April 2015 | 5:30 am
Reata Pharmaceuticals Receives Orphan Drug
Reata Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of breakthrough medicines for difficult-to-treat diseases, today announced that the FDA Office of Orphan Products Development ...
Posted on 10 April 2015 | 4:30 am
Tokai Pharmaceuticals to Present at Upcoming
Tokai Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases
Posted on 10 April 2015 | 4:00 am
Adamas Pharmaceuticals to Present at 2015
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that Gregory T. Went, PhD., Chief Executive Officer, will present at the 2015 Needham Healthcare Conference in New York on Tuesday, April ...
Posted on 9 April 2015 | 1:01 pm
Amgen wins approval for second biotech
Sanofi and partner Regeneron Pharmaceuticals Inc. won FDA approval for that drug last month. Analysts estimate between 8 million to 10 million patients are covered under the FDA-approved labeling for the drugs. But some experts worry the drugs could ...
Posted on 27 August 2015 | 10:18 pm
Singapore manufacturing falls 6.1%
SINGAPORE: The Republic's industrial production fell year-on-year for the sixth straight month in July, hurt by lower output of electronics, pharmaceuticals and rigs, EDB reported on Wednesday (Aug 26). Production in the electronics cluster fell 5.8 per ...
Posted on 27 August 2015 | 9:52 pm
New Data on Actelion Pulmonary Arterial
Actelion Pharmaceuticals Ltd recently announced in a press release that new data on its investigational drug selexipag (Uptravi®) and the approved macitentan (Opsumit®) for pulmonary arterial hypertension will be presented at the upcoming European ...
Posted on 27 August 2015 | 9:45 pm
Teva Pharmaceutical Industries Ltd (ADR) Not
Teva has successfully switched patients to the 3x/week (40mg) from the once/daily (20mg)…” Teva continues to face generic competition on its once/daily (20mg) regimen from Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and Sandoz, the generic drug unit of ...
Posted on 27 August 2015 | 9:12 pm
ACADIA Pharmaceuticals Stock Rating
ACADIA Pharmaceuticals (NASDAQ:ACAD)‘s stock had its “outperform” rating reaffirmed by Cowen and Company in a note issued to investors on Friday, MarketBeat reports. They currently have a $50.00 price target on the biopharmaceutical company’s stock.
Posted on 27 August 2015 | 8:43 pm
NJ drug company execs charged with insider
Executives at two leading drug companies were among six people arrested Monday and charged with insider trading in what federal prosecutors said was a five-year-long scheme that netted more than $1 million.
Posted on 19 November 2012 | 10:46 am
AG: J&J must pay $52M in Pa. drug pricing
Johnson & Johnson must pay $52 million in damages and penalties after a Pennsylvania judge found the pharmaceutical company falsely reported the prices of its drugs.
Posted on 17 December 2010 | 3:19 pm
Pfizer will buy King Pharmaceuticals for
Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company.
Posted on 11 October 2010 | 5:12 pm
Endo Pharma paying $1.2 billion for
Drug developer Endo Pharmaceuticals Holdings Inc. said Tuesday it is buying Qualitest Pharmaceuticals for $1.2 billion in a move to diversify its business and strengthen its position in the generic and pain drug markets.
Posted on 28 September 2010 | 3:22 am
Teva plans to appeal lawsuit verdict
Drugmaker Teva Pharmaceutical Industries Ltd. plans to appeal a $356 million Las Vegas district court verdict awarded to a plaintiff who says he contracted hepatitis C when one of Teva's drug vials was used by more than one patient.
Posted on 8 May 2010 | 8:56 am